Sensei Biotherapeutics Inc (SNSE): Next-Year EPS Estimate 92.04%
As of 2026-06-04, Sensei Biotherapeutics Inc (SNSE) has a next-year EPS growth estimate of 92.04%.
SNSE was first flagged by our screen on 2026-05-31, when analyst consensus for its next-year EPS growth was revised from 90.52% to 92.17%. Current-year growth is projected at -389.77%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 92.04%
- EPS growth this year
- -389.77%
- EPS next quarter (est)
- -$3.37
- Last price
- $16.60
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 92.04% | -389.77% | -$3.37 | $16.60 |
| 2026-06-03 | 92.17% | -389.25% | -$3.34 | $15.85 |
| 2026-06-02 | 92.17% | -389.25% | -$3.34 | $16.09 |
| 2026-06-01 | 92.17% | -389.25% | -$3.34 | $19.79 |
| 2026-05-31 | 92.17% | -389.25% | -$3.34 | $21.14 |
| 2026-05-28 | 90.52% | -508.13% | -$8.20 | $17.59 |
| 2026-05-27 | 90.52% | -508.13% | -$8.20 | $16.65 |
| 2026-05-26 | 90.52% | -508.13% | -$8.20 | $16.47 |
| 2026-05-25 | 90.52% | -508.13% | -$8.20 | $17.79 |
| 2026-05-24 | 90.52% | -508.13% | -$8.20 | $17.79 |
| 2026-05-21 | 90.52% | -508.13% | -$8.20 | $17.56 |
| 2026-05-20 | 90.52% | -508.13% | -$8.20 | $17.58 |
| 2026-05-19 | 90.52% | -508.13% | -$8.20 | $16.77 |
| 2026-05-18 | 90.52% | -508.13% | -$8.20 | $19.91 |
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Sensei Biotherapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Sensei Biotherapeutics Inc (SNSE) has a next-year EPS growth estimate of 92.04%, based on analyst consensus.
When was the latest EPS estimate revision for SNSE?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 92.17% to 92.04%.
What sector and industry does Sensei Biotherapeutics Inc belong to?▾
Sensei Biotherapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SNSE appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Sensei Biotherapeutics Inc (SNSE) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports